Bora CDMO Bora CDMO

X

CAS 38862-65-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
Ethyl Olivetolate
Also known as: 38862-65-6, Ethyl olivetolate, Benzoic acid, 2,4-dihydroxy-6-pentyl-, ethyl ester, Jlk7qtk6y2, Unii-jlk7qtk6y2, Schembl8750720
Molecular Formula
C14H20O4
Molecular Weight
252.31  g/mol
InChI Key
ALCUWNWVZNZFHQ-UHFFFAOYSA-N
FDA UNII
JLK7QTK6Y2

1 2D Structure

Ethyl Olivetolate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl 2,4-dihydroxy-6-pentylbenzoate
2.1.2 InChI
InChI=1S/C14H20O4/c1-3-5-6-7-10-8-11(15)9-12(16)13(10)14(17)18-4-2/h8-9,15-16H,3-7H2,1-2H3
2.1.3 InChI Key
ALCUWNWVZNZFHQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCCC1=C(C(=CC(=C1)O)O)C(=O)OCC
2.2 Other Identifiers
2.2.1 UNII
JLK7QTK6Y2
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 38862-65-6

2. Ethyl Olivetolate

3. Benzoic Acid, 2,4-dihydroxy-6-pentyl-, Ethyl Ester

4. Jlk7qtk6y2

5. Unii-jlk7qtk6y2

6. Schembl8750720

7. Dtxsid70499528

8. Ethyl2,4-dihydroxy-6-pentylbenzoate

9. Mfcd11618127

10. Zinc13339596

11. Ethyl 2,4-dihydroxy-6-n-pentylbenzoate

12. As-47679

13. Cs-0152317

14. Ft-0651431

15. Beta-resorcylic Acid, 6-pentyl-, Ethyl Ester

16. F15230

17. 2,4-dihydroxy-6-pentyl-benzoic Acid Ethyl Ester

18. A935028

19. .beta.-resorcylic Acid, 6-pentyl-, Ethyl Ester

2.4 Create Date
2007-02-08
3 Chemical and Physical Properties
Molecular Weight 252.31 g/mol
Molecular Formula C14H20O4
XLogP34.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count7
Exact Mass252.13615911 g/mol
Monoisotopic Mass252.13615911 g/mol
Topological Polar Surface Area66.8 Ų
Heavy Atom Count18
Formal Charge0
Complexity254
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
38862-65-6
Cannabidiol
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

EMWA 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
38862-65-6
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salt...
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salts Embio’s facility at Mahad ( 180 Kms from Bombay by road ) has been audited and approved by the Australian TGA, and the US FDA Embio has also been granted the Certificate of Suitability ( CoS ) for its Pseudoephedrine HCl
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
38862-65-6
Tetrahydrocannabinol
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 10...
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 100 years. It is engaged in the research and development, production and marketing of intermediates, APIs and specialty chemicals. The products are exported to major pharmaceutical manufacturers in Europe, the United States, and Japan. Affirmed by customers. At present, the main shareholder of the company is the Sanshang Bank Group. The strong shareholder lineup and excellent management team have made the company's performance grow year by year, and it was listed on the Taiwan Stock Exchange in 2004.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
38862-65-6
Cannabidiol
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 10...
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 100 years. It is engaged in the research and development, production and marketing of intermediates, APIs and specialty chemicals. The products are exported to major pharmaceutical manufacturers in Europe, the United States, and Japan. Affirmed by customers. At present, the main shareholder of the company is the Sanshang Bank Group. The strong shareholder lineup and excellent management team have made the company's performance grow year by year, and it was listed on the Taiwan Stock Exchange in 2004.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY